EB-BH2025
/ Essen Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 31, 2024
BAH244: Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
(clinicaltrials.gov)
- P1/2 | N=85 | Recruiting | Sponsor: Essen Biotech | Not yet recruiting ➔ Recruiting | Initiation date: Oct 2024 ➔ Jul 2024
CAR T-Cell Therapy • Enrollment open • Trial initiation date • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology • CD5 • CD7
1 to 1
Of
1
Go to page
1